Emcure Pharmaceuticals IPO aims for ₹1,952 crore.
Strategic financial leap Emcure Pharmaceuticals, a prominent Pune-based pharmaceutical company, plans to collect ₹1,952 crore through an IPO. On July...
Strategic financial leap Emcure Pharmaceuticals, a prominent Pune-based pharmaceutical company, plans to collect ₹1,952 crore through an IPO. On July...
Both qualified institutional buyers (QIBs) and non-institutional investors (NIIs) showed a great deal of interest in Allied Blenders and Distillers'...
The crossover utility vehicle (CUV) Cloud EV from MG is scheduled to debut in India shortly. The Cloud EV, which...
In intraday trading on Friday, shares of Central Depository Services (India) Limited (CDSL) surged 13% to a record high of...
The second-biggest telecom provider in India, Bharti Airtel, has announced that it will be raising its mobile rates as of...
Given that Indian government bonds are included in JPMorgan Chase & Co.'s esteemed emerging markets index, India is expected to...
Rally Breaks Records The BSE Sensex and NSE Nifty50 hit record highs on June 27, 2024. The Sensex reached a...
India's 2024 Top Brands The Brand Finance 'India 100 2024' ranking again ranks Tata Group as India's most valuable brand...
Overview of Settlement Indian IT giant Infosys and CEO Salil Parekh settled insider trading accusations with SEBI by paying ₹25...
Market Position Improved by Strategic Acquisition The board of UltraTech Cement, India's largest cement business, approved a ₹1,885 crore acquisition...